Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa : vimarsana.com

Dr Wagner discusses unmet needs for patients with PEComa, ongoing research to address these gaps, and findings from the AMPECT trial.

Related Keywords

Boston , Massachusetts , United States , Caroline Seymour , Andrewj Wagner , Dana Faber Cancer Institute , Harvard Medical School , Facebook , Linkedin , Twitter , Live On Air , Ambulatory Oncology , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , D , Hd , Patients With Pecoma , Ampect Trial ,